Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
Kestra (Nasdaq: KMTS) appointed Curtis Kopf as Senior Vice President of Customer Experience, a newly created role overseeing the patient journey for the ASSURE WCD from order approval through therapy completion and device return.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Kestra (Nasdaq: KMTS) appointed Curtis Kopf as Senior Vice President of Customer Experience, a newly created role overseeing the patient journey for the ASSURE WCD from order approval through therapy completion and device return. He will align people, processes, and technology to support providers and patients.
Kopf previously led global customer experience at Insulet and held senior experience and digital roles at REI. According to Kestra, his appointment coincides with investments in commercial capabilities and artificial intelligence initiatives aimed at driving operating leverage in customer-facing operations and supporting the company’s next stage of growth.
Details
News Market Reaction – KMTS
On Aug 26, the day this news came out, KMTS closed 1.30% below the previous close.
Data tracked by StockTitan Argus for the Aug 26 session.
Key Figures
- Announcement date
- August 26, 2026
- Appointment announcement
- Organization size
- More than 1,000 employees
- Mr. Kopf's prior global service organization at Insulet
Historical Context
-
Up to $200 million term loan facility with non-dilutive financing structure
-
Revenue growth and gross-margin expansion accompanied the fiscal-year results
-
Company scheduled fiscal fourth-quarter results for July 14
-
Company announced a BofA Securities healthcare conference presentation
-
FDA-approved ASSURE WCD algorithm update highlighted at HRS 2026
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
artificial intelligence technical
operating leverage financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE® WCD.
“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk patients. That mission guides both the technology we create and the experience we deliver, helping patients begin therapy with confidence and remain engaged, connected, and protected throughout their care,” said Brian Webster, President and Chief Executive Officer. “Curtis brings the vision and experience to lead that journey end to end, harnessing data and automation to scale patient support, strengthen performance at every stage, and extend the impact of the ASSURE WCD and the broader Cardiac Recovery System platform to more patients.”
Mr. Kopf has extensive experience leading customer experience, digital transformation, and large-scale service operations. Most recently, he served as Group Vice President, Global Customer Experience at Insulet Corporation, where he led a global organization of more than 1,000 employees across digital, customer service, and customer success and helped advance the adoption of artificial intelligence across a large-scale service organization. Previously, he served as Chief Experience Officer and Chief Digital Officer at REI, where he led customer experience, digital, analytics, innovation, and service organizations.
“Every interaction is an opportunity to build confidence, remove friction, and help patients stay connected throughout their cardiac recovery,” said Mr. Kopf. “Kestra has built a powerful combination of differentiated technology and deeply committed patient support. I look forward to working with the team to anticipate patient needs, simplify each step of the journey, and scale that experience while preserving the human connection that matters most.”
The appointment of Mr. Kopf comes as Kestra invests in its commercial capabilities, including multiple artificial intelligence initiatives designed to drive operating leverage across its customer-facing operations. These investments are expected to position Kestra for its next stage of growth by advancing the technology that protects patients and the experience that supports them.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit www.kestramedical.com.
Media contact Rhiannon Pickus rhiannon.pickus@kestramedical.com Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.